Compounds and uses thereof

US12275723B2 · kind B2 · utility

Assignee

• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Matthew C. Lucas · Sunnyvale, US
• Bertrand Le Bourdonnec · Coatesville, US
• Iwona Wrona · Sharon, US
• Bhaumik Pandya · Bedford, US
• Parcharee Tivitmahaisoon · San Francisco, US
• Kerem Ozboya · Cambridge, US
• Benjamin Vincent · Cambridge, US
• Daniel TARDIFF · Arlington, US
• Jeff S. Piotrowski · Madison, US
• Eric Solis · Milford, US
• Robert Scannevin · Hopkinton, US
• Chee-Yeun Chung · Cambridge, US
• Rebecca ARON · Cambridge, US
• Kenneth Rhodes · Belmont, US

Key dates

• Filing date: Sep 27, 2023
• Grant date: Apr 15, 2025
• Expiry date: Sep 27, 2043

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N33/574
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.